Simplex Trading
KYMR icon

Simplex Trading’s Kymera Therapeutics KYMR Stock Holding History

Simplex Trading’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
15,500
+14,400
+1,309% +$1.14M ﹤0.01% 2236
2025
Q4 		$85.6K Sell
1,100
-1,900
-63% -$128K ﹤0.01% 5154
2025
Q3 		$169K Sell
3,000
-27,100
-90% -$1.22M ﹤0.01% 5139
2025
Q2 		$1.31M Buy
30,100
+2,400
+9% +$82.6K ﹤0.01% 2501
2025
Q1 		$758K Buy
27,700
+24,400
+739% +$889K ﹤0.01% 2969
2024
Q4 		$132K Hold
3,300
– – ﹤0.01% 4927
2024
Q3 		$156K Sell
3,300
-700
-18% -$30.9K ﹤0.01% 4769
2024
Q2 		$119K Sell
4,000
-4,700
-54% -$163K ﹤0.01% 5194
2024
Q1 		$349K Sell
8,700
-2,200
-20% -$78.7K ﹤0.01% 4225
2023
Q4 		$277K Buy
10,900
+2,000
+22% +$35.8K ﹤0.01% 4314
2023
Q3 		$123K Sell
8,900
-6,700
-43% -$135K ﹤0.01% 4883
2023
Q2 		$358K Sell
15,600
-91,300
-85% -$2.62M ﹤0.01% 3651
2023
Q1 		$3.17M Sell
106,900
-50,400
-32% -$1.63M ﹤0.01% 1592
2022
Q4 		$3.93M Buy
157,300
+154,300
+5,143% +$4.11M ﹤0.01% 1366
2022
Q3 		$65K Buy
3,000
+300
+11% +$7.91K ﹤0.01% 6079
2022
Q2 		$53K Sell
2,700
-10,500
-80% -$245K ﹤0.01% 6414
2022
Q1 		$558K Buy
13,200
+12,900
+4,300% +$545K ﹤0.01% 3708
2021
Q4 		$19K Sell
300
-4,500
-94% -$262K ﹤0.01% 8411
2021
Q3 		$269K Buy
4,800
+200
+4% +$11.6K ﹤0.01% 5088
2021
Q2 		$223K Buy
+4,600
New +$200K ﹤0.01% 5514

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Simplex Trading's KYMR Position: Q1 2025 in Review

Simplex Trading sold out of Kymera Therapeutics (KYMR) in Q1 2025, closing a stake of 20 shares — an estimated $729 sold.

Simplex Trading first reported a position in KYMR in Q2 2021 and held it in 7 quarters. The position peaked at $157K in Q1 2022. 173 funds tracked by Wall St. Rank hold KYMR as of Q1 2025.

  • Simplex Trading reported no remaining Kymera Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 20 Kymera Therapeutics shares in Q1 2025, an estimated $729.
  • Simplex Trading first reported a position in Kymera Therapeutics in Q2 2021 and held it in 7 quarters.
  • Simplex Trading's Kymera Therapeutics position peaked at $157K in Q1 2022.
  • 173 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.